Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 5
1988 1
1989 9
1990 8
1991 12
1992 15
1993 14
1994 15
1995 27
1996 21
1997 20
1998 27
1999 24
2000 18
2001 20
2002 21
2003 27
2004 28
2005 25
2006 37
2007 26
2008 26
2009 27
2010 38
2011 44
2012 26
2013 51
2014 58
2015 63
2016 54
2017 54
2018 44
2019 49
2020 63
2021 58
2022 36
2023 52
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,044 results

Results by year

Filters applied: . Clear all
Page 1
Autosomal dominant polycystic kidney disease.
Cornec-Le Gall E, Alam A, Perrone RD. Cornec-Le Gall E, et al. Lancet. 2019 Mar 2;393(10174):919-935. doi: 10.1016/S0140-6736(18)32782-X. Epub 2019 Feb 25. Lancet. 2019. PMID: 30819518 Review.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and one of the most common causes of end-stage kidney disease. ...Implementation of these advances has the potential to delay kidney …
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and one …
Autosomal dominant tubulointerstitial kidney disease.
Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, Bleyer AJ. Devuyst O, et al. Nat Rev Dis Primers. 2019 Sep 5;5(1):60. doi: 10.1038/s41572-019-0109-9. Nat Rev Dis Primers. 2019. PMID: 31488840 Review.
Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a recently defined entity that includes rare kidney diseases characterized by tubular damage and interstitial fibrosis in the absence of glomerular lesions, with inescapable progression to …
Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a recently defined entity that includes rare kidney …
Genetic Mechanisms of ADPKD.
Kim DY, Park JH. Kim DY, et al. Adv Exp Med Biol. 2016;933:13-22. doi: 10.1007/978-981-10-2041-4_2. Adv Exp Med Biol. 2016. PMID: 27730431 Review.
Autosomal dominant polycystic kidney disease is caused by mutation of PKD1 (polycystic kidney disease-1) or PKD2 (polycystic kidney disease-2). ...
Autosomal dominant polycystic kidney disease is caused by mutation of PKD1 (polycystic kidney dise …
Autosomal dominant polycystic kidney disease.
Torres VE, Harris PC, Pirson Y. Torres VE, et al. Lancet. 2007 Apr 14;369(9569):1287-1301. doi: 10.1016/S0140-6736(07)60601-1. Lancet. 2007. PMID: 17434405 Review.
Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. ...
Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. ...
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
Chebib FT, Perrone RD, Chapman AB, Dahl NK, Harris PC, Mrug M, Mustafa RA, Rastogi A, Watnick T, Yu ASL, Torres VE. Chebib FT, et al. J Am Soc Nephrol. 2018 Oct;29(10):2458-2470. doi: 10.1681/ASN.2018060590. Epub 2018 Sep 18. J Am Soc Nephrol. 2018. PMID: 30228150 Free PMC article. Review.
In the past, the treatment of autosomal dominant polycystic kidney disease (ADPKD) has been limited to the management of its symptoms and complications. Recently, the US Food and Drug Administration (FDA) approved tolvaptan as the first drug treatment …
In the past, the treatment of autosomal dominant polycystic kidney disease (ADPKD) has been limited to the manag …
Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.
Nowak KL, Hopp K. Nowak KL, et al. Clin J Am Soc Nephrol. 2020 Apr 7;15(4):577-584. doi: 10.2215/CJN.13291019. Epub 2020 Feb 21. Clin J Am Soc Nephrol. 2020. PMID: 32086281 Free PMC article. Review.
Autosomal dominant polycystic kidney disease is characterized by progressive development and enlargement of kidney cysts, leading to ESKD. ...Beyond single-intervention trials focused on metabolic reprograming in autosomal dominant …
Autosomal dominant polycystic kidney disease is characterized by progressive development and enlargement of k …
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies.
Lanktree MB, Haghighi A, di Bari I, Song X, Pei Y. Lanktree MB, et al. Clin J Am Soc Nephrol. 2021 May 8;16(5):790-799. doi: 10.2215/CJN.02320220. Epub 2020 Jul 20. Clin J Am Soc Nephrol. 2021. PMID: 32690722 Free PMC article. Review.
Autosomal dominant polycystic kidney disease is the most common monogenic cause of ESKD. ...By comprehensive screening of multiple cystic disease and modifier genes, targeted gene panel, whole-exome, or whole-genome sequencing is expected to improve bo …
Autosomal dominant polycystic kidney disease is the most common monogenic cause of ESKD. ...By comprehensive scr …
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
Cornec-Le Gall E, Torres VE, Harris PC. Cornec-Le Gall E, et al. J Am Soc Nephrol. 2018 Jan;29(1):13-23. doi: 10.1681/ASN.2017050483. Epub 2017 Oct 16. J Am Soc Nephrol. 2018. PMID: 29038287 Free PMC article. Review.
Data indicate significant phenotypic and genotypic overlap, plus a common pathogenesis, between two groups of inherited disorders, autosomal dominant polycystic kidney diseases (ADPKD), a significant cause of ESRD, and autosomal dominant …
Data indicate significant phenotypic and genotypic overlap, plus a common pathogenesis, between two groups of inherited disorders, autoso …
Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment.
Reiterová J, Tesař V. Reiterová J, et al. Int J Mol Sci. 2022 Mar 19;23(6):3317. doi: 10.3390/ijms23063317. Int J Mol Sci. 2022. PMID: 35328738 Free PMC article. Review.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic renal disease, with an estimated prevalence between 1:1000 and 1:2500. ...
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic renal disease, with an estimated …
Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
Chebib FT, Torres VE. Chebib FT, et al. Am J Kidney Dis. 2021 Aug;78(2):282-292. doi: 10.1053/j.ajkd.2020.12.020. Epub 2021 Mar 8. Am J Kidney Dis. 2021. PMID: 33705818 Review.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of kidney failure, accounting for 5%-10% of cases. ...A complex interaction of these prognostic factors determines the number of kidney cysts and thei …
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of kidney failure …
1,044 results